Stocks · News reference
Crude Oil Tumbles Over 5%; Empire State Manufacturing Index Falls In June
US stocks gain on peace agreement with Iran, Nasdaq up 2%, Dow up 1.1%, S&P 500 up 1.54%. Tech shares jump 2.8%, energy stocks fall 3.5%. Empire State manufacturing index drops to 5.7. Industrial production up 0.1%. Housing market index declines to 35.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Datavault AI Inc. Investors Have Until October 5th to Contact Bragar Eagel & Squire, P.C. Seeking Lead Plaintiff Role
A class action lawsuit has been filed against Datavault AI Inc. (NASDAQ: DVLT) for allegedly making materially false and misleading statements regarding corporate partnerships, trading volume on its platform, and undisclosed connections to a convicted felon. Investors who purchased securities between September 4, 2024 and October 30, 2025 have until October 5, 2026 to apply as lead plaintiff.
What's Going On With Datavault AI Stock Wednesday?
Datavault AI (DVLT) rose over 4% premarket as Nasdaq granted a 180-day extension to meet its $1 minimum bid price rule.
Reported August 25: Datavault AI Gets Nasdaq Extension Through Feb. 22, 2027 To Regain Compliance
https://www.sec.gov/ix?doc=/Archives/edgar/data/1682149/000110465926100819/tm2624018d1_8k.htm
Stock Market Today: Dow Jones Futures Rise, S&P 500 Slips Ahead of NVDA Q2 as Core PCE Comes in at 3.3% — Zoom, Intuit, Datavault AI in Focus (UPDATED)
U.S. stock futures were mixed on Wednesday, as the Dow Jones index rose, while the S&P 500 and Nasdaq 100 indices slipped.
Elicio Therapeutics to Participate at the H.C. Wainwright 28th Annual Global Investment Conference
Elicio Therapeutics announced that its CEO Robert Connelly and Chief Scientific Officer Pete DeMuth will participate in a fireside chat at the H.C. Wainwright 28th Annual Global Investment Conference on September 14, 2026. The clinical-stage biotech company is developing next-generation immunotherapies for KRAS-driven cancers, with its lead program ELI-002 7P targeting the most common KRAS mutations found in approximately 25% of solid tumors.